Elsevier

Toxicology Letters

Volume 195, Issues 2–3, 2 June 2010, Pages 161-168
Toxicology Letters

Spleen injury and apoptotic pathway in mice caused by titanium dioxide nanoparticules

https://doi.org/10.1016/j.toxlet.2010.03.1116Get rights and content

Abstract

Nanoparticulate titanium dioxide (TiO2) has been demonstrated to decrease immunity of mice, but very little is known about the injury of spleen involved immunomodulation and its molecular mechanism. In order to understand the spleen injury induced by intraperitoneal injection of TiO2 nanoparticules (NPs) for consecutive 45 days, the spleen pathological changes, apoptosis, the expression levels of the apoptotic genes and their proteins, and oxidative stress in the mouse spleen were investigated. The results demonstrated that TiO2 NPs had obvious accumulation in the mouse spleen, leading to congestion and lymph nodule proliferation of spleen tissue, and splenocyte apoptosis. TiO2 NPs effectively activated caspase-3 and -9, decreased the Bcl-2 the levels of gene and protein, and increase the levels of Bax, and cytochrome c genes and their protein expression, promoted ROS accumulation. Taken together, this study indicated that TiO2 NPs-induced apoptosis in the mouse splenocyte via mitochondrial-mediated pathway. These findings provide strong evidence that the TiO2 NPs can induce the spleen pathological changes, apoptosis, leading to the reduction of immunity of mice.

Introduction

Titanium (Ti) either pure or in alloys is extensively used for a wide range of implanted medical devices, such as dental implants, joint replacements, cardiovascular stents, and spinal fixation devices, due to its advantageous combination of physico-chemical and biological properties. However, under mechanical stress or altered physiological conditions such as low pH, Ti-based implants can release large amounts of particle debris, both in the micrometer and nanometer size range (Brien et al., 1992, Buly et al., 1992, Arys et al., 1998, Cunningham et al., 2002). As new types of photo-catalyst, anti-ultraviolet light agents, and photoelectric effect agents, TiO2 nanoparticules (NPs) are used in a variety of consumer products, such as toothpastes, sunscreens, cosmetics, food products (Gurr et al., 2005), paints and surface coatings (Fisher and Egerton, 2001), and in the environmental decontamination of air, soil, and water (Esterkin et al., 2005, Choi et al., 2006). The toxicological concern is due to the distinct properties of nanoparticles, such as small size, high number per given mass, large specific surface area, and generation of free radicals (Lynch et al., 2006).

It has been suggested that the biological responses to nanoparticles may exceed those elicited by micron-sized particles (Borm et al., 2006, Ne et al., 2006). Recent studies indicate that TiO2 NPs are toxic to lung, liver, and gill of animals. Previous studies had shown that TiO2 NPs produced pulmonary inflammation, cytotoxicity and adverse rat lung tissue effects by intratracheally instillation (Afaq et al., 1998, Warheit et al., 2007a, Warheit et al., 2007b), and interstitial thickening in the rat lung (Liu et al., 2009a). TiO2 NPs were demonstrated to cause the oxidative stress in the gill of rainbow trout (Federici et al., 2007), and accumulated in the kidneys but had minimal effect on kidney functions of rainbow trout (Scown et al., 2009). TiO2 NPs with oral gavage increased the ratio of alanine aminotransferase to aspartate aminotransferase, the activity of lactate dehydrogenase and the liver weight, and caused the hepatocyte necrosis and damaged the liver functions of mice (Wang et al., 2007), and with intraperitoneal injection could also increase the activities of alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase, leucine acid peptide, pseudocholinesterase, lactate dehydrogenase, and the levels of triglycerides, total protein, and albumin level, damaging the liver function (Liu et al., 2009b), and caused hepatocyte apoptosis and inflammatory cascade, which was closely related to significant alteration of both mRNA and protein expression levels of several inflammatory cytokines (Ma et al., 2009). The enhancement of lipid peroxides in the mouse brain and liver caused by TiO2 NPs implicated an oxidative attack that was activated by a reduction of the antioxidative defense mechanism (Ma et al., 2010, Liu et al., 2010), and caused DNA cleavage of the mouse liver (Li et al., 2010). The liver function damage in mice caused by intragastric administration with TiO2 NPs was demonstrated to be closely associated with the damage of blood system haemostasis and the reduction of immunity (Duan et al., 2010). In addition, this last may be due to the spleen damage. The spleen is the largest immune organ in animals, participating in immune response, generating lymphocytes, eliminating aging erythrocytes and storing blood. The immune system is affected by the toxicological activity of many pollutants, including heavy metals (Bernier et al., 1995, Burns et al., 1995). Heavy metals can cause dose dependent immunomodulation by disturbing the fine balanced mechanisms of immune cell regulation. Depending on the particular metal, its concentration, biologic availability and a range of other factors, the outcome of this modulation may be either immunosuppression or immunoenhancement (Burns et al., 1995, Khangarot et al., 1999, Krocova et al., 2000, Lawrence and McCabe, 2002). However, to our best knowledge, so far, the researches on splenic toxicity of nanomaterials are rarely reported. Is the bio-toxicity of nanomaterials on the spleen also related to apoptosis, leading to the decrease of immunity and the damage of liver function? And the mechanisms of nanomaterials-induced toxicity in animals need investigation.

In the present paper, the accumulation of TiO2 NPs, the spleen pathological changes, the splenocyte ultrastructure, the expression levels of the apoptotic genes and their proteins, and oxidative stress in the mouse spleen were investigated to understand mechanism of the splenic injury in mice caused by this compound.

Section snippets

Chemicals, preparation and characterization

TiO2 (100% anatase, CAS#: 13463-67-7, VK-TA05) was purchased from Hangzhou Wanjing New Material Co. Ltd. (China). A 0.5% w/v hydroxypropyl-methylcellulose K4M (HPMC, K4M) was used as a suspending agent. Each TiO2 powder was dispersed onto the surface of 0.5% w/v HPMC solution, and then the suspending solutions containing TiO2 particles were treated by ultrasonic for 15–20 min and mechanically vibrated for 2 min or 3 min.

The particle sizes of powder or suspended in 0.5% w/v HPMC solvent at time 0

TiO2 NPs characteristics

X-ray diffraction measurements (Fig. 1) show that TiO2 NPs had the anatase structure. The average grain size calculated from the broadening of the (1 0 1) XRD peak of anatase using Scherrer's equation was about 7 nm. The transmission electron micrographs demonstrated that the average particle sizes of powder (Fig. 2a), suspended in 0.5% w/v HPMC solvent (5 mg/ml) at time 0, and or after incubation 24 h (Fig. 2b and c) were about 6–7 nm, respectively, which is well matched by the XRD results. The

Discussion

The results of this study indicate that the intraperitoneal injection of various doses of TiO2 NPs can increase coefficients of the spleen (Fig. 3), and that its significant accumulation in the mouse spleen (Fig. 4) can induce histopathological changes of spleen, including the congestion and lymph nodule proliferation (Fig. 5). And we observed splenocyte mitochondria swelling, splenocyte nucleus exhibiting the classical morphology characteristics of apoptosis or necrosis: a reduction in nuclear

Conclusion

In this study, we have demonstrated that TiO2 NPs had obvious accumulation in the mouse spleen. This in turn led to congestion and lymph nodule proliferation of spleen tissue, apoptosis and apoptotic signaling activation at the gene and protein levels, and ROS accumulation. Moreover, this study indicated that TiO2 NPs-induced apoptosis in the mouse splenocyte via mitochondrial-mediated pathway. These findings provide strong evidence that the TiO2 NPs can induce the spleen pathological changes,

Conflict of interest

We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.

Acknowledgements

This work was supported by the National Natural Science Foundation of China (grant no. 30901218), the Bringing New Ideas Foundation of postgraduate of Medical College of Soochow University, the Medical Development Foundation of Soochow University (grant no. EE120701), the National Bringing New Ideas Foundation of Student of China (grant nos. 57315427, 57315927), and the Soochow University Start-up Fund (grant no. Q4134918).

References (51)

  • D.A. Lawrence et al.

    Immunomodulation by metals

    Int. Immunopharmacol.

    (2002)
  • K.J. Livak et al.

    Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method

    Methods

    (2001)
  • R. Liu et al.

    Pulmonary toxicity induced by three forms of titanium dioxide nanoparticles via intra-tracheal instillation in rats

    Prog. Nat. Sci.

    (2009)
  • W.H. Liu et al.

    Saint validation of a quantitative method for real time PCR kinetics

    Biophys. Res. Commun.

    (2002)
  • L.L. Ma et al.

    Oxidative stress in the brain of mice caused by translocated nanoparticulate TiO2 delivered to the abdominal cavity

    Biomaterials

    (2010)
  • J. Nourooz-Zadeh et al.

    Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine

    Anal. Biochem.

    (1994)
  • C.P. Oliveira et al.

    Protection against liver ischemia-reperfusion injury in rats by silymarin or verapamil

    Transplant. Proc.

    (2001)
  • J.X. Wang et al.

    Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration

    Toxicol. Lett.

    (2007)
  • J.X. Wang et al.

    Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO2 nanoparticles

    Toxicology

    (2008)
  • D.B. Warheit et al.

    Pulmonary toxicity study in rats with three forms of ultrafine-TiO2 particles: differential responses related to surface properties

    Toxicology

    (2007)
  • D.B. Warheit et al.

    Development of a base of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management

    Toxicol. Lett.

    (2007)
  • F. Afaq et al.

    Cytotoxicity, pro-oxidant effects and antioxidant depletion in rat lung alveolar macrophages exposed to ultrafine titanium dioxide

    J. Appl. Toxicol.

    (1998)
  • A. Arys et al.

    Analysis of titanium dental implants after failure of osseointegration: combined histological, electron microscopy, and X-ray photoelectron spectroscopy approach

    J. Biomed. Mater. Res.

    (1998)
  • J. Bernier et al.

    Immunotoxicity of heavy metals in relation to Great Lakes

    Environ. Health Perspect.

    (1995)
  • P.J. Borm et al.

    The potential risks of nanomaterials: a review carried out for ECETOC

    Particle Fibre Toxicol.

    (2006)
  • Cited by (100)

    • Blood titanium level as a biomarker of orthopaedic implant wear

      2019, Journal of Trace Elements in Medicine and Biology
    View all citing articles on Scopus
    1

    These authors contributed equally to this work.

    View full text